Clinical Trials Browser

Phase 2 × Histone Deacetylase Inhibitors × Plasma cell × Clear all

NCT00792506 2022-02-02

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma

NCT00005624 2012-09-25

CI-994 in Treating Patients With Advanced Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell